2214-6237

Journal of Clinical & Translational Endocrinology

Elsevier

Health Score

0 Fair

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 439 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact439 DOIs
2

Attach ORCID iDs across 294 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact294 DOIs
3

Deposit reference lists for 18 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact18 DOIs

DOIs for this ISSN

Showing the top 5 of 439 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Optimizing insulin injection technique and its effect on blo… (10.1016/j.jcte.2014.07.006)
Abstract ORCID
90.31 63
2 Metabolic bone disease of prematurity (10.1016/j.jcte.2014.06.004)
Abstract ORCID
84.95 49
3 Examining diabetes distress, medication adherence, diabetes… (10.1016/j.jcte.2017.07.003)
Abstract ORCID
83.60 46
4 SGLT2 inhibitors: Beyond glycemic control (10.1016/j.jcte.2024.100335)
Abstract ORCID
82.66 44
5 Is oxidative stress of adipocytes a cause or a consequence o… (10.1016/j.jcte.2018.11.001)
Abstract ORCID
81.16 41
6 An overview of Charcot’s neuroarthropathy (10.1016/j.jcte.2020.100239)
Abstract ORCID
81.16 41
7 The interdisciplinary team in type 2 diabetes management: Ch… (10.1016/j.jcte.2016.12.001)
Abstract ORCID
80.64 40
8 The association between vitamin D level and diabetic periphe… (10.1016/j.jcte.2017.04.001)
Abstract ORCID
80.10 39
9 Hyperthyroidism in the pregnant woman: Maternal and fetal as… (10.1016/j.jcte.2019.100190)
Abstract ORCID
75.26 31
10 Vitamin D status, receptor gene polymorphisms, and supplemen… (10.1016/j.jcte.2014.08.001)
Abstract ORCID
74.57 30
11 Graves’ disease and mental disorders (10.1016/j.jcte.2019.100207)
Abstract ORCID
74.57 30
12 Beneficial effects of oral pure caffeine on oxidative stress (10.1016/j.jcte.2017.10.001)
Abstract ORCID
73.86 29
13 Anti-inflammatory benefits of semaglutide: State of the art (10.1016/j.jcte.2024.100340)
Abstract ORCID
73.86 29
14 The prolactin receptor: Diverse and emerging roles in pathop… (10.1016/j.jcte.2015.05.001)
Abstract ORCID
73.12 28
15 Serum omentin-1 levels in type 2 diabetic obese women in rel… (10.1016/j.jcte.2018.05.003)
Abstract ORCID
73.12 28
16 Incidence of hypocalcemia and hypercalcemia in hospitalized… (10.1016/j.jcte.2018.05.004)
Abstract ORCID
73.12 28
17 Fear of hypoglycaemia and self-management in type 1 diabetes (10.1016/j.jcte.2016.02.002)
Abstract ORCID
72.36 27
18 The effect of text message support on diabetes self-manageme… (10.1016/j.jcte.2016.12.005)
Abstract ORCID
72.36 27
19 The role of vitamin D in tuberculosis (10.1016/j.jcte.2014.08.002)
Abstract ORCID
71.57 26
20 COVID-19 and chronic fatigue syndrome: An endocrine perspect… (10.1016/j.jcte.2021.100284)
Abstract ORCID
71.57 26
21 Benign thyroid disease in pregnancy: A state of the art revi… (10.1016/j.jcte.2016.11.001)
Abstract ORCID
70.75 25
22 Lipid disorders in patients with renal failure: Role in card… (10.1016/j.jcte.2016.08.002)
Abstract ORCID
69.90 24
23 Cancer, sunlight and vitamin D (10.1016/j.jcte.2014.10.001)
Abstract ORCID
68.09 22
24 Influence of aerobic exercise training on cardiovascular and… (10.1016/j.jcte.2014.07.004)
Abstract ORCID
67.12 21
25 Eicosanoids: Atherosclerosis and cardiometabolic health (10.1016/j.jcte.2020.100216)
Abstract ORCID
67.12 21
26 Evaluation of telephone and virtual visits for routine pedia… (10.1016/j.jcte.2020.100238)
Abstract ORCID
67.12 21
27 Outcomes of hospitalized diabetic foot patients in a multi-d… (10.1016/j.jcte.2014.10.002)
Abstract ORCID
66.11 20
28 Relationship of treatment satisfaction to health-related qua… (10.1016/j.jcte.2015.03.002)
Abstract ORCID
66.11 20
29 Evidence-based review of statin use in patients with HIV on… (10.1016/j.jcte.2017.01.004)
Abstract ORCID
66.11 20
30 Chemokines in hyperthyroidism (10.1016/j.jcte.2019.100196)
Abstract ORCID
65.05 19
31 Improved insulin injection technique, treatment satisfaction… (10.1016/j.jcte.2020.100217)
Abstract ORCID
65.05 19
32 Risk factors of erectile dysfunction among diabetes patients… (10.1016/j.jcte.2020.100232)
Abstract ORCID
65.05 19
33 Management of chronic kidney disease: The current novel and… (10.1016/j.jcte.2024.100354)
Abstract ORCID
65.05 19
34 Testosterone deficiency and chronic kidney disease (10.1016/j.jcte.2024.100365)
Abstract ORCID
65.05 19
35 Short-term effectiveness of a culturally tailored educationa… (10.1016/j.jcte.2017.01.002)
Abstract ORCID
63.94 18
36 Impact of heart failure and dialysis in the prognosis of dia… (10.1016/j.jcte.2018.01.002)
Abstract ORCID
63.94 18
37 Exploring glycosuria as a mechanism for weight and fat mass… (10.1016/j.jcte.2013.12.001)
Abstract ORCID
62.76 17
38 Efficacy and safety of twice-daily treatment with canagliflo… (10.1016/j.jcte.2014.04.001)
Abstract ORCID
62.76 17
39 Factors associated with a diabetes diagnosis and late diabet… (10.1016/j.jcte.2014.07.002)
Abstract ORCID
62.76 17
40 The effect of diabetes case management and Diabetes Resource… (10.1016/j.jcte.2017.03.003)
Abstract ORCID
62.76 17
41 Vitamin D receptor gene polymorphisms and 25(OH) vitamin D:… (10.1016/j.jcte.2018.11.005)
Abstract ORCID
62.76 17
42 Disparities in prediabetes and type 2 diabetes prevalence be… (10.1016/j.jcte.2019.100191)
Abstract ORCID
62.76 17
43 Metabolomic analysis reveals amino-acid responses to an oral… (10.1016/j.jcte.2014.03.003)
Abstract ORCID
61.52 16
44 Treating psychological insulin resistance in type 2 diabetes (10.1016/j.jcte.2016.11.005)
Abstract ORCID
61.52 16
45 Development and validation of a scale to measure diabetes bu… (10.1016/j.jcte.2021.100251)
Abstract ORCID
61.52 16
46 Obesity in cystic fibrosis (10.1016/j.jcte.2021.100276)
Abstract ORCID
61.52 16
47 Practical aspects of diabetes technology use: Continuous glu… (10.1016/j.jcte.2021.100282)
Abstract ORCID
61.52 16
48 The role of modulators in cystic fibrosis related diabetes (10.1016/j.jcte.2021.100286)
Abstract ORCID
61.52 16
49 Association between obesity phenotypes of insulin resistance… (10.1016/j.jcte.2019.100210)
Abstract ORCID
60.21 15
50 Professional continuous glucose monitoring and endocrinology… (10.1016/j.jcte.2021.100254)
Abstract ORCID
60.21 15